Advertisement
  • Building COVID-19 Vaccine Confidence

    Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.

    by Kevin McLaughlin

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Q&A

    Up for Debate

    Hematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.

    by Marci A. Landsmann

  • Get Involved

    Cakes for Cancer

    Inspired by a family friend, Chase Sloan has published a recipe book with proceeds going toward cancer research.

    by Erin O'Donnell

  • Survivor Profile

    A Return to Carnival

    With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

    by Lindsey Konkel

  • Forward Look

    Making Cancer Clinical Trials More Inclusive

    Despite efforts by policymakers, a gender gap persists in clinical trial participation.

    by Lindsey Konkel

  • Policy Matters

    Research Advocacy During COVID-19

    Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.

    by Brandon Leonard, MA, and Marc Johnson, MPP

  • A Drive for Diversity

    African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

    by Jon Kelvey

  • Patient Advocates Tune in for Precision Medicine Primer

    Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

    by Kevin McLaughlin

  • Immunotherapy Options for Breast Cancer

    Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

    by Anna Goshua